GlucoTrack, Inc. Files 8-K: Agreements, Equity Sales, Officer Changes
Ticker: GCTK · Form: 8-K · Filed: Jul 31, 2024 · CIK: 1506983
| Field | Detail |
|---|---|
| Company | Glucotrack, INC. (GCTK) |
| Form Type | 8-K |
| Filed Date | Jul 31, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $5.00, $50,000, $1.875, $2.625, $3.375 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, officer-changes
TL;DR
GlucoTrack filed an 8-K detailing new agreements, equity sales, and exec changes. Watch closely.
AI Summary
On July 30, 2024, GlucoTrack, Inc. entered into a material definitive agreement, likely related to financing or operations, as indicated by the filing of an 8-K. The company also reported on the creation of a direct financial obligation and unregistered sales of equity securities. Additionally, there were changes in directors or officers and compensatory arrangements.
Why It Matters
This 8-K filing indicates significant corporate actions by GlucoTrack, Inc., including financial obligations and equity transactions, which could impact its financial standing and stock performance.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered equity sales, suggesting potential financial shifts and corporate restructuring that carry inherent risks.
Key Players & Entities
- GlucoTrack, Inc. (company) — Registrant
- Integrity Applications, Inc. (company) — Former Company Name
FAQ
What was the nature of the material definitive agreement entered into by GlucoTrack, Inc. on July 30, 2024?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What type of financial obligation was created by GlucoTrack, Inc.?
The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant.
Were there any unregistered sales of equity securities by GlucoTrack, Inc.?
Yes, the filing explicitly lists 'Unregistered Sales of Equity Securities' as an item of information.
What changes occurred regarding directors or officers at GlucoTrack, Inc.?
The filing mentions 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', indicating potential changes in leadership and compensation.
When was the company formerly known as Integrity Applications, Inc.?
The date of the name change from Integrity Applications, Inc. to GlucoTrack, Inc. was December 3, 2010.
Filing Stats: 1,389 words · 6 min read · ~5 pages · Grade level 10.8 · Accepted 2024-07-31 17:15:10
Key Financial Figures
- $5.00 — osing Price of the Common stock exceeds $5.00 per share for a period of five (5) cons
- $50,000 — mes subject to a judgement of more than $50,000, (iii) voluntary bankruptcy, or (iv) in
- $1.875 — irst Warrant is for 2,133,334 shares at $1.875 per share. The second Warrant is for 1,
- $2.625 — cond Warrant is for 1,523,810 shares at $2.625 per share. The third Warrant is for 1,1
- $3.375 — hird Warrant is for 1,185,186 shares at $3.375 per share. As part of the transaction
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex10-1.htm (EX-10.1) — 41KB
- ex10-2.htm (EX-10.2) — 29KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-029775.txt ( ) — 329KB
- gctk-20240730.xsd (EX-101.SCH) — 3KB
- gctk-20240730_lab.xml (EX-101.LAB) — 33KB
- gctk-20240730_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Glucotrack, Inc. Date: July 31, 2024 By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer